Arcturus Therapeutics Announces Approval From Vietnam Ministry Of Health To Proceed Into Phase 3b Study For ARCT-154, A Next Generation STARR mRNA Vaccine Targeting SARS-CoV-2 Delta Variant And Other Variants Of Concern